Adjuvant IO: Survival Advantage ' Big News ' in Renal Cancer Adjuvant IO: Survival Advantage ' Big News ' in Renal Cancer

A 40% reduced risk for death from renal cancer, as reported by KEYNOTE-564, tops Dr Brian Rini ' s list of takeaways from ASCO GU 2024. Also discussed are updates on doublet therapy in advanced disease.Medscape
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news